1951 - 1960 of 6078 Results
Title
Year
- De Novo and Dominantly Inherited SPTAN1 Mutations Cause Spastic Paraplegia and Cerebellar Ataxia2022OPENTitle: De Novo and Dominantly Inherited SPTAN1 Mutations Cause Spastic Paraplegia and Cerebellar AtaxiaJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 6Start Page: 1175End Page: 1186Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28959Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232883Citation Count: 20
-
OPENTitle: Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s diseaseJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 28Issue #:Start Page: 1End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2022.02.007Best OA location URL: http://www.cell.com/article/S216225312200035X/pdfCitation Count: 18
-
OPENTitle: Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophyJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 32Issue #: 2Start Page: 103End Page: 114Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10286-022-00853-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10286-022-00853-6.pdfCitation Count: 10
-
OPENTitle: Divergence Between Informant and Self-Ratings of Activities of Daily Living Impairments in Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.838674Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.838674/pdfCitation Count: 4
-
OPENTitle: Trends in the Utilization of Teleneurology and Other Healthcare Resources Prior to and During the COVID-19 Pandemic in an Urban, Tertiary Health SystemJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.834708Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.834708/pdfCitation Count: 9
-
OPENTitle: Semantic Integration of Multi-Modal Data and Derived Neuroimaging Results Using the Platform for Imaging in Precision Medicine (PRISM) in the Arkansas Imaging Enterprise System (ARIES)Journal Name: Frontiers in Artificial IntelligencePublisher: Frontiers Media SAVol: 4Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/frai.2021.649970Best OA location URL: https://www.frontiersin.org/articles/10.3389/frai.2021.649970/pdfCitation Count: 11
-
OPENTitle: Special Issue on new therapeutic approaches to Parkinson diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 208Issue #:Start Page: 108998End Page: 108998Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998Citation Count: 4
-
OPENTitle: Assessing Gq-GPCR–induced human astrocyte reactivity using bioengineered neural organoidsJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1083/jcb.202107135Best OA location URL: https://rupress.org/jcb/article-pdf/221/4/e202107135/1428539/jcb_202107135.pdfCitation Count: 17
-
OPENTitle: How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 PandemicJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 9Start Page: 801End Page: 801Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2022.1510Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2789055/jama_suran_2022_mn_220006_1645750114.50702.pdfCitation Count: 5
-
OPENTitle: Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 65End Page: 73Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.022Best OA location URL: http://www.prd-journal.com/article/S135380202200030X/pdfCitation Count: 17